Company
Trially
Trially® HIPAA-compliant AI platform matches, engages and helps enroll patients into trials with ~95% accuracy and 10x ROI for sites.
Also known as Trially Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Customers
- Built for physicians, research sites, sponsors, and CROs.
- Legal name
- Trially Inc.
Record updated 28 September 2026
About
Trially AI is shaping the future of clinical trial recruitment by matching, engaging and enrolling qualified patients faster. Proven to multiply enrollment rates by up to 6x, reduce screen failures by 73% and automate screening with ~95% accuracy. Trially AI automates patient matching and agentic outreach from any source – including EHRs, fully compliant with HIPAA, SOC 2, FDA CFR 21 Part 11 and ISO 27001. Designed for physicians, research sites, CROs and pharmaceutical sponsors, Trially empowers you to achieve outstanding results in clinical research.
Funding snapshot
- Total raised
- $4.8MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Seed, $4.7M2025-09-16
Funding rounds
- Round, 2025
- $4.8M2025-08-08, SEC form D sold, 13 investors
Products
- Web
- Trially Connect
- Web
- Trially Intelligence
- Web
- Trially Match